Professor Lyle Armstrong is a leading stem cell scientist whose career has been defined by pioneering contributions to human pluripotent stem cell biology, developmental modelling and regenerative medicine. As one of the scientists responsible for generating and depositing one of the first human embryonic stem cell lines into the UK Stem Cell Bank in 2004, he has played a prominent role in the development of the stem cell field over the past two decades. He subsequently led Work Package 2 of the EU/IMI StemBANCC consortium, overseeing the generation of induced pluripotent stem cell (iPSC) lines from approximately 450 patients with neurodegenerative disorders, creating a globally important resource that continues to underpin studies of human development, disease modelling and drug discovery. His research has focused on developing advanced human tissue models from pluripotent stem cells, including retinal organoids that faithfully recapitulate key aspects of human retinal development and function. Through these efforts, he has helped establish internationally recognised platforms for studying retinal disease, testing therapeutics and reducing animal usage through the application of human stem cell-based models.

Professor Armstrong has also made substantial contributions to understanding human eye development and disease. His work has advanced knowledge of retinal organoid development, transcriptional regulation and chromatin dynamics, while contributing to landmark studies including the first single-cell atlas of the human cornea and the identification of novel limbal progenitor cell populations. He has played an important role in the development and clinical translation of stem cell-based therapies for limbal stem cell deficiency, helping to establish autologous limbal and oral mucosal epithelial cell transplantation as effective regenerative treatments. Beyond his research achievements, he has supervised numerous PhD students, postdoctoral researchers and early-career scientists who have progressed to leadership roles across academia, healthcare and biotechnology, demonstrating a longstanding commitment to mentoring and capacity building within the field.

His wider contributions extend across scientific leadership, innovation and public engagement. Professor Armstrong has served in key editorial roles for leading stem cell journals, contributed to national and international funding review panels, and helped coordinate major European collaborative programmes. He also played a pivotal role in founding and developing Newcells Biotech Ltd., a successful Newcastle University spin-out company that has grown from a small academic venture into an internationally recognised provider of human iPSC-based disease models and drug discovery platforms. In addition, he has contributed to UK science policy as an expert witness to the House of Commons Science and Technology Committee during deliberations that informed the Human Fertility and Embryology Act 2008. Collectively, his scientific achievements, leadership experience and commitment to translational research make him exceptionally well placed to support and advance national resources and initiatives in human developmental biology.